VIRIDIEN 92.050 € (-2,80 %)
CVC CAPITAL 15.150 € (+0,66 %)
ATON 0.016 € (-7,14 %)
L'OREAL 379.350 € (+1,05 %)
VALERIO TX 0.732 € (-3,68 %)
BNP PARIBAS ACT.A 108.620 € (-0,71 %)
EDP 4.605 € (-1,16 %)
SOCIETE GENERALE 78.690 € (-1,70 %)
EIFFAGE 119.700 € (+0,84 %)
TOTALENERGIES 78.050 € (+1,50 %)
CM.COM 6.900 € (+0,44 %)
LAKEFRONT BIOTHER. 24.500 € (+2,85 %)
WOLTERS KLUWER 69.580 € (-0,57 %)
SODEXO 56.450 € (+1,16 %)
STELLANTIS NV 4.539 € (+3,54 %)
AIR LIQUIDE 167.300 € (+0,16 %)
ENTECH 9.980 € (-0,40 %)
UMG 14.655 € (-1,05 %)
ADYEN 1 042.000 € (-1,16 %)
ASM INTERNATIONAL 840.600 € (-0,21 %)
WERELDHAVE 18.400 € (0,00 %)
ADP 110.000 € (+1,01 %)
ASML HOLDING 1 545.900 € (+0,27 %)
FASTNED 38.250 € (-0,65 %)
PATRIMOINE ET COMM 26.200 € (-2,24 %)
NEXANS 137.900 € (-0,07 %)
DBT 0.053 € (-6,64 %)
VALBIOTIS 0.832 € (+0,97 %)
STMICROELECTRONICS 44.790 € (-1,15 %)
SHELL PLC 39.800 € (+0,04 %)
ABN AMRO BANK N.V. 40.620 € (-0,64 %)
B.COM.PORTUGUES 1.098 € (-0,09 %)
SCHNEIDER ELECTRIC 296.350 € (+0,42 %)
VALNEVA 2.958 € (+0,37 %)
ESSILORLUXOTTICA 164.100 € (+0,12 %)
ALFEN 13.000 € (-4,69 %)
CLARIANE 4.020 € (+0,25 %)
INNATE PHARMA 1.752 € (-1,24 %)
HAFFNER ENERGY 0.648 € (-5,95 %)
CORTICEIRA AMORIM 6.720 € (+0,15 %)
ABIVAX 103.500 € (+0,58 %)
THALES 265.800 € (-0,08 %)
SANOFI 78.070 € (+0,51 %)
DEEZER 1.210 € (-0,82 %)
INVENTIVA 4.015 € (+2,55 %)
SAFRAN 356.800 € (+1,05 %)
PROSUS 37.165 € (+0,55 %)
ING GROEP N.V. 30.470 € (-0,47 %)
KENDRION 19.620 € (+0,10 %)
LVMH 452.400 € (+1,04 %)
AIRBUS 211.650 € (+0,88 %)
VINCI 120.550 € (+0,96 %)
LEGRAND 135.500 € (+0,26 %)
TECHNIP ENERGIES 30.460 € (-0,13 %)
X-FAB 6.050 € (-3,43 %)
ADOCIA 4.230 € (+0,81 %)
ORANGE 16.195 € (+0,09 %)
MAAT PHARMA 3.255 € (+11,09 %)
AXA 44.310 € (-0,54 %)
EUTELSAT COMMUNIC. 1.968 € (-3,67 %) |
09/01/2023 16:26
EQS-Adhoc: SÜSS MicroTec SE: Sales and EBIT margin in 2022 fiscal year forecast to exceed market expectationsEQS-Ad-hoc: SÜSS MicroTec SE / Key word(s): Preliminary Results SÜSS MicroTec SE: Sales and EBIT margin in 2022 fiscal year forecast to exceed market expectations Garching, January 9, 2023 – Based on initial calculations, the Management Board of SÜSS MicroTec SE has determined that the projected sales and earnings development for the 2022 fiscal year exceeds current market expectations. In the extraordinarily strong fourth quarter of 2022, the Company delivered and received customer acceptance of more systems than expected, and expects to achieve sales of EUR 100 to 105 million. Total sales in the 2022 fiscal year are thus expected to amount to between EUR 295 and 300 million, thereby reaching a new record level. Annual sales are thus significantly higher than the current average market expectation of EUR 272 million, and also higher than the Company's most recently substantiated forecast of November 10, 2022 (lower part of the range of EUR 270 to 300 million). Based on initial calculations, Management expects the EBIT margin in the 2022 fiscal year to be in a range of 8.5% to 10% (current market expectation: 8.3%; substantiated forecast of November 10, 2022: lower end of the forecast range of 8.5% to 10.5%). Order entry in the 2022 fiscal year totaled approximately EUR 445 million. This announcement is based on preliminary and unaudited Group figures. The complete annual financial report with final data on the Company's sales, earnings and order entry will be published on March 31, 2023. Contact: SÜSS MicroTec SE Sven Koepsel Investor Relations Schleissheimer Strasse 90 85748 Garching, Germany Tel.: +49 (0)89 32007-151 Email: sven.koepsel@suss.com 09-Jan-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
1530761 09-Jan-2023 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière